Menu

It is not long since the treatment opportunities of metastatic prostate cancer have been introduced to mankind

January 30, 2019 0 Comment

It is not long since the treatment opportunities of metastatic prostate cancer have been introduced to mankind. In such revolutionary period many non-hormonal & hormonal agents like Enzalutamide have been incorporated as a vital treatment alternative for prostate cancer and with the use of Enzalutamide the overall patient survival rate went up than other therapeutic agents. Being a non-steroidal 2nd generation anti-androgen it was approved for the treatment of metastatic CRPC, even if it was employed in post-docetaxel and chemotherapy-naïve setting. In this study the pharmacological peculiarities of enzalutamide, the efficacy studies which made it possible to approve this anti-androgen as well as its place in the consecutive treatment of metastatic prostate cancer is discussed here.

x

Hi!
I'm Eddie!

Would you like to get a custom essay? How about receiving a customized one?

Check it out